PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By ...
Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR to European Markets with CE Mark Clearance Countable PCR delivers single-molecule precision for Europe's most demanding ...
Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; ...
Countable Labs, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology. The platform is ideal for any ...
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company’s financing ...
Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction. The system extends the company’s Countable PCR technology, which ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics PALO ALTO, Calif.-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results